Skip to main content
Erschienen in: Endocrine 2/2016

13.09.2016 | Original Article

Evaluation of patient-reported outcomes data in structured diabetes education intervention: 2-year follow-up data of patient empowerment programme

verfasst von: Carlos K. H. Wong, Cindy L. K. Lam, Eric Y. F. Wan, Anca K. C. Chan, C. H. Pak, Frank W. K. Chan, William C. W. Wong

Erschienen in: Endocrine | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

To examine the effects of a structured group-based education programme, patient empowerment programme (PEP), compared with usual care on 2-year changes in patient-reported outcomes (PRO) in patients with diabetes mellitus (DM). A prospective observational study of 715 patients (PEP/non-PEP: 390/325) was conducted to complete the baseline PRO survey and followed up for 2 years. Health-related quality of life (HRQOL) was measured using the short-form 12 at baseline and annually at two follow-up assessments, which yielded physical and mental component summary and SF-6D preference-based scores. Perceived control over diabetes and general health status were measured using the patient enablement instrument (PEI) and global rating scale (GRS) at follow-ups. When compared with non-PEP, PEP participants significantly reported improvement in health condition (GRS score > 0; 24.55 % vs 10.16 %; odds ratio = 2.502; P = 0.018) in 2 years and enabled the self-perceived control over diabetes (PEI score > 0; 72.20 % vs 38.40 %; odds ratio = 3.25; P < 0.001) in 1-year follow-up but no sustained effects in year 2 (52.65 % vs 39.04 %; odds ratio = 1.366; P = 0.265). There were no significant differences between PEP and non-PEP groups in the changes in quality of life scores (all P > 0.05) at 1 year. Although HRQOL scores deteriorated over 2-year period in both groups, PEP participants reported similar changes in HRQOL scores to that of non-PEP. PEP for DM patients preserved self-perceived disease control and health condition, whereas PEP participants perceived their HRQOL similar to that of non-PEP participants. Findings of PRO should be considered alongside clinical outcomes when evaluating the overall benefits of PEP.
Literatur
1.
2.
Zurück zum Zitat W.L. Bennett, N.M. Maruthur, S. Singh, J.B. Segal, L.M. Wilson, R. Chatterjee, S.S. Marinopoulos, M.A. Puhan, P. Ranasinghe, L. Block, W.K. Nicholson, S. Hutfless, E.B. Bass, S. Bolen, Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann. Intern. Med. 154(9), 602–613 (2011). doi:10.7326/0003-4819-154-9-201105030-00336 CrossRefPubMedPubMedCentral W.L. Bennett, N.M. Maruthur, S. Singh, J.B. Segal, L.M. Wilson, R. Chatterjee, S.S. Marinopoulos, M.A. Puhan, P. Ranasinghe, L. Block, W.K. Nicholson, S. Hutfless, E.B. Bass, S. Bolen, Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann. Intern. Med. 154(9), 602–613 (2011). doi:10.​7326/​0003-4819-154-9-201105030-00336 CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat H.C. Yeh, T.T. Brown, N. Maruthur, P. Ranasinghe, Z. Berger, Y.D. Suh, L.M. Wilson, E.B. Haberl, J. Brick, E.B. Bass, S.H. Golden, Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann. Intern. Med. 157(5), 336–347 (2012). doi:10.7326/0003-4819-157-5-201209040-00508 CrossRefPubMed H.C. Yeh, T.T. Brown, N. Maruthur, P. Ranasinghe, Z. Berger, Y.D. Suh, L.M. Wilson, E.B. Haberl, J. Brick, E.B. Bass, S.H. Golden, Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann. Intern. Med. 157(5), 336–347 (2012). doi:10.​7326/​0003-4819-157-5-201209040-00508 CrossRefPubMed
5.
Zurück zum Zitat E. Loveman, G.K. Frampton, A.J. Clegg, The clinical effectiveness of diabetes education models for type 2 diabetes: a systematic review. Health Technol. Assess. 12(9), 1–116 (2008)CrossRef E. Loveman, G.K. Frampton, A.J. Clegg, The clinical effectiveness of diabetes education models for type 2 diabetes: a systematic review. Health Technol. Assess. 12(9), 1–116 (2008)CrossRef
6.
Zurück zum Zitat A. Coppola, L. Sasso, A. Bagnasco, A. Giustina, C. Gazzaruso, The role of patient education in the prevention and management of type 2 diabetes: an overview. Endocrine (2015). doi:10.1007/s12020-015-0775-7 A. Coppola, L. Sasso, A. Bagnasco, A. Giustina, C. Gazzaruso, The role of patient education in the prevention and management of type 2 diabetes: an overview. Endocrine (2015). doi:10.​1007/​s12020-015-0775-7
7.
Zurück zum Zitat S.L. Norris, J. Lau, S.J. Smith, C.H. Schmid, M.M. Engelgau, Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 25(7), 1159–1171 (2002)CrossRefPubMed S.L. Norris, J. Lau, S.J. Smith, C.H. Schmid, M.M. Engelgau, Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 25(7), 1159–1171 (2002)CrossRefPubMed
8.
Zurück zum Zitat A. Steinsbekk, L.O. Rygg, M. Lisulo, M.B. Rise, A. Fretheim, Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus: a systematic review with meta-analysis. BMC Health Serv. Res. 12, 213 (2012). doi:10.1186/1472-6963-12-213 CrossRefPubMedPubMedCentral A. Steinsbekk, L.O. Rygg, M. Lisulo, M.B. Rise, A. Fretheim, Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus: a systematic review with meta-analysis. BMC Health Serv. Res. 12, 213 (2012). doi:10.​1186/​1472-6963-12-213 CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat L. Fan, S. Sidani, Effectiveness of diabetes self-management education intervention elements: a meta-analysis. Can. J. Diabetes 33(1), 18–26 (2009)CrossRef L. Fan, S. Sidani, Effectiveness of diabetes self-management education intervention elements: a meta-analysis. Can. J. Diabetes 33(1), 18–26 (2009)CrossRef
10.
Zurück zum Zitat C. Acquadro, R. Berzon, D. Dubois, N.K. Leidy, P. Marquis, D. Revicki, M. Rothman, P.R.O.H. Group, Incorporating the patient’s perspective into drug development and communication: an ad hoc task force report of the patient-reported outcomes (pro) harmonization group meeting at the Food and Drug Administration, February 16, 2001. Value Health 6(5), 522–531 (2003). doi:10.1046/j.1524-4733.2003.65309.x CrossRefPubMed C. Acquadro, R. Berzon, D. Dubois, N.K. Leidy, P. Marquis, D. Revicki, M. Rothman, P.R.O.H. Group, Incorporating the patient’s perspective into drug development and communication: an ad hoc task force report of the patient-reported outcomes (pro) harmonization group meeting at the Food and Drug Administration, February 16, 2001. Value Health 6(5), 522–531 (2003). doi:10.​1046/​j.​1524-4733.​2003.​65309.​x CrossRefPubMed
11.
Zurück zum Zitat Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI): Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. J. Am. Med. Assoc. 307(15), 1636–1640 (2012). doi:10.1001/jama.2012.466 Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI): Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. J. Am. Med. Assoc. 307(15), 1636–1640 (2012). doi:10.​1001/​jama.​2012.​466
13.
Zurück zum Zitat B.B. Reeve, K.W. Wyrwich, A.W. Wu, G. Velikova, C.B. Terwee, C.F. Snyder, C. Schwartz, D.A. Revicki, C.M. Moinpour, L.D. McLeod, J.C. Lyons, W.R. Lenderking, P.S. Hinds, R.D. Hays, J. Greenhalgh, R. Gershon, D. Feeny, P.M. Fayers, D. Cella, M. Brundage, S. Ahmed, N.K. Aaronson, Z. Butt, ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual. Life Res. 22(8), 1889–1905 (2013). doi:10.1007/s11136-012-0344-y CrossRefPubMed B.B. Reeve, K.W. Wyrwich, A.W. Wu, G. Velikova, C.B. Terwee, C.F. Snyder, C. Schwartz, D.A. Revicki, C.M. Moinpour, L.D. McLeod, J.C. Lyons, W.R. Lenderking, P.S. Hinds, R.D. Hays, J. Greenhalgh, R. Gershon, D. Feeny, P.M. Fayers, D. Cella, M. Brundage, S. Ahmed, N.K. Aaronson, Z. Butt, ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual. Life Res. 22(8), 1889–1905 (2013). doi:10.​1007/​s11136-012-0344-y CrossRefPubMed
14.
Zurück zum Zitat M.A. Powers, J. Bardsley, M. Cypress, P. Duker, M.M. Funnell, A. Hess Fischl, M.D. Maryniuk, L. Siminerio, E. Vivian, Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. Diabetes Care 38(7), 1372–1382 (2015). doi:10.2337/dc15-0730 CrossRefPubMed M.A. Powers, J. Bardsley, M. Cypress, P. Duker, M.M. Funnell, A. Hess Fischl, M.D. Maryniuk, L. Siminerio, E. Vivian, Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. Diabetes Care 38(7), 1372–1382 (2015). doi:10.​2337/​dc15-0730 CrossRefPubMed
16.
Zurück zum Zitat J. Sperl-Hillen, S. Beaton, O. Fernandes, A. Von Worley, G. Vazquez-Benitez, E. Parker, A. Hanson, J. Lavin-Tompkins, P. Glasrud, H. Davis, K. Adams, W. Parsons, C.V. Spain, Comparative effectiveness of patient education methods for type 2 diabetes: a randomized controlled trial. Arch. Intern. Med. 171(22), 2001–2010 (2011). doi:10.1001/archinternmed.2011.507 CrossRefPubMed J. Sperl-Hillen, S. Beaton, O. Fernandes, A. Von Worley, G. Vazquez-Benitez, E. Parker, A. Hanson, J. Lavin-Tompkins, P. Glasrud, H. Davis, K. Adams, W. Parsons, C.V. Spain, Comparative effectiveness of patient education methods for type 2 diabetes: a randomized controlled trial. Arch. Intern. Med. 171(22), 2001–2010 (2011). doi:10.​1001/​archinternmed.​2011.​507 CrossRefPubMed
18.
Zurück zum Zitat K. Khunti, L.J. Gray, T. Skinner, M.E. Carey, K. Realf, H. Dallosso, H. Fisher, M. Campbell, S. Heller, M.J. Davies, Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care. Br. Med. J. 344, e2333 (2012). doi:10.1136/bmj.e2333 CrossRef K. Khunti, L.J. Gray, T. Skinner, M.E. Carey, K. Realf, H. Dallosso, H. Fisher, M. Campbell, S. Heller, M.J. Davies, Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care. Br. Med. J. 344, e2333 (2012). doi:10.​1136/​bmj.​e2333 CrossRef
19.
Zurück zum Zitat M.J. Davies, S. Heller, T.C. Skinner, M.J. Campbell, M.E. Carey, S. Cradock, H.M. Dallosso, H. Daly, Y. Doherty, S. Eaton, C. Fox, L. Oliver, K. Rantell, G. Rayman, K. Khunti, E. Diabetes, Self Management for, O., Newly Diagnosed, C.: Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. Br. Med. J. 336(7642), 491–495 (2008). doi:10.1136/bmj.39474.922025.BE M.J. Davies, S. Heller, T.C. Skinner, M.J. Campbell, M.E. Carey, S. Cradock, H.M. Dallosso, H. Daly, Y. Doherty, S. Eaton, C. Fox, L. Oliver, K. Rantell, G. Rayman, K. Khunti, E. Diabetes, Self Management for, O., Newly Diagnosed, C.: Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. Br. Med. J. 336(7642), 491–495 (2008). doi:10.​1136/​bmj.​39474.​922025.​BE
21.
Zurück zum Zitat C.K.H. Wong, W.C.W. Wong, C.L.K. Lam, Y.F. Wan, W.H.T. Wong, K.L. Chung, D. Dai, E.L.H. Tsui, D.Y.T. Fong, Effects of patient empowerment programme (PEP) on clinical outcomes and health service utilization in type 2 diabetes mellitus in primary care: an observational matched cohort study. PLoS ONE 9(5), e95328 (2014). doi:10.1371/journal.pone.0095328 CrossRefPubMedPubMedCentral C.K.H. Wong, W.C.W. Wong, C.L.K. Lam, Y.F. Wan, W.H.T. Wong, K.L. Chung, D. Dai, E.L.H. Tsui, D.Y.T. Fong, Effects of patient empowerment programme (PEP) on clinical outcomes and health service utilization in type 2 diabetes mellitus in primary care: an observational matched cohort study. PLoS ONE 9(5), e95328 (2014). doi:10.​1371/​journal.​pone.​0095328 CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat C.K.H. Wong, W.C.W. Wong, Y.F. Wan, A.K.C. Chan, K.L. Chung, F.W.K. Chan, C.L.K. Lam, Patient empowerment programme in primary care reduced all-cause mortality and cardiovascular diseases in patients with type 2 diabetes mellitus: a population-based propensity-matched cohort study. Diabetes Obes. Metab. 17(2), 128–135 (2015). doi:10.1111/dom.12397 CrossRefPubMed C.K.H. Wong, W.C.W. Wong, Y.F. Wan, A.K.C. Chan, K.L. Chung, F.W.K. Chan, C.L.K. Lam, Patient empowerment programme in primary care reduced all-cause mortality and cardiovascular diseases in patients with type 2 diabetes mellitus: a population-based propensity-matched cohort study. Diabetes Obes. Metab. 17(2), 128–135 (2015). doi:10.​1111/​dom.​12397 CrossRefPubMed
23.
Zurück zum Zitat C.K.H. Wong, W.C.W. Wong, E.Y.F. Wan, A.K.C. Chan, F.W.K. Chan, C.L.K. Lam, Macrovascular and microvascular disease in obese patients with type 2 diabetes attending structured diabetes education program: a population-based propensity-matched cohort analysis of patient empowerment programme (PEP). Endocrine. 53(2), 412–422 (2016). doi:10.1007/s12020-015-0843-z C.K.H. Wong, W.C.W. Wong, E.Y.F. Wan, A.K.C. Chan, F.W.K. Chan, C.L.K. Lam, Macrovascular and microvascular disease in obese patients with type 2 diabetes attending structured diabetes education program: a population-based propensity-matched cohort analysis of patient empowerment programme (PEP). Endocrine. 53(2), 412–422 (2016). doi:10.​1007/​s12020-015-0843-z
24.
Zurück zum Zitat C.K.H. Wong, W.C.W. Wong, Y.F. Wan, A.K.C. Chan, F.W.C. Chan, C.L.K. Lam, Patient empowerment programme (PEP) and risk of microvascular diseases among patients with type 2 diabetes mellitus in primary care: a population-based propensity matched cohort study. Diabetes Care 38(8), e116–117 (2015). doi:10.2337/dc14-2213 CrossRefPubMed C.K.H. Wong, W.C.W. Wong, Y.F. Wan, A.K.C. Chan, F.W.C. Chan, C.L.K. Lam, Patient empowerment programme (PEP) and risk of microvascular diseases among patients with type 2 diabetes mellitus in primary care: a population-based propensity matched cohort study. Diabetes Care 38(8), e116–117 (2015). doi:10.​2337/​dc14-2213 CrossRefPubMed
25.
Zurück zum Zitat C.K.H. Wong, W.C.W. Wong, E.Y.F. Wan, A.K.C. Chan, F.W.K. Chan, C.L.K. Lam, Effect of a structured diabetes education programme in primary care on hospitalizations and emergency department visits among people with type 2 diabetes mellitus: results from the patient empowerment programme. Diabetic Med. (2015). doi:10.1111/dme.12969 C.K.H. Wong, W.C.W. Wong, E.Y.F. Wan, A.K.C. Chan, F.W.K. Chan, C.L.K. Lam, Effect of a structured diabetes education programme in primary care on hospitalizations and emergency department visits among people with type 2 diabetes mellitus: results from the patient empowerment programme. Diabetic Med. (2015). doi:10.​1111/​dme.​12969
26.
Zurück zum Zitat C.K.H. Wong, W.C.W. Wong, E. Wan, W. Wong, F.W.K. Chan, C.L.K. Lam, Increased number of structured diabetes education attendance was not associated with the improvement in patient-reported health-related quality of life: results from patient empowerment programme (PEP). Health Qual. Life Outcomes 13(1), 126 (2015). doi:10.1186/s12955-015-0324-3 CrossRefPubMedPubMedCentral C.K.H. Wong, W.C.W. Wong, E. Wan, W. Wong, F.W.K. Chan, C.L.K. Lam, Increased number of structured diabetes education attendance was not associated with the improvement in patient-reported health-related quality of life: results from patient empowerment programme (PEP). Health Qual. Life Outcomes 13(1), 126 (2015). doi:10.​1186/​s12955-015-0324-3 CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat C.L.K. Lam, E.Y.Y. Tse, B. Gandek, Is the standard SF-12 health survey valid and equivalent for a Chinese population? Qual. Life Res. 14(2), 539–547 (2005)CrossRefPubMed C.L.K. Lam, E.Y.Y. Tse, B. Gandek, Is the standard SF-12 health survey valid and equivalent for a Chinese population? Qual. Life Res. 14(2), 539–547 (2005)CrossRefPubMed
28.
Zurück zum Zitat C.L.K. Lam, C.K.H. Wong, E.T.P. Lam, Y.Y.C. Lo, W.W. Huang, Population norm of Chinese (HK) SF-12 health survey_version 2 of Chinese adults in Hong Kong. HK Practitioner 32(2), 77–86 (2010) C.L.K. Lam, C.K.H. Wong, E.T.P. Lam, Y.Y.C. Lo, W.W. Huang, Population norm of Chinese (HK) SF-12 health survey_version 2 of Chinese adults in Hong Kong. HK Practitioner 32(2), 77–86 (2010)
29.
Zurück zum Zitat C.K.H. Wong, Y.Y.C. Lo, W.H.T. Wong, C.S.C. Fung, The associations of body mass index with physical and mental aspects of health-related quality of life in Chinese patients with type 2 diabetes mellitus: results from a cross-sectional survey. Health Qual. Life Outcomes 11(1), 142 (2013). doi:10.1186/1477-7525-11-142 CrossRefPubMedPubMedCentral C.K.H. Wong, Y.Y.C. Lo, W.H.T. Wong, C.S.C. Fung, The associations of body mass index with physical and mental aspects of health-related quality of life in Chinese patients with type 2 diabetes mellitus: results from a cross-sectional survey. Health Qual. Life Outcomes 11(1), 142 (2013). doi:10.​1186/​1477-7525-11-142 CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat J.E. Brazier, J. Roberts, The estimation of a preference-based measure of health from the SF-12. Med. Care 42(9), 851–859 (2004)CrossRefPubMed J.E. Brazier, J. Roberts, The estimation of a preference-based measure of health from the SF-12. Med. Care 42(9), 851–859 (2004)CrossRefPubMed
31.
Zurück zum Zitat S.M. McGhee, J. Brazier, C.L.K. Lam, L.C. Wong, J. Chau, A. Cheung, A. Ho, Quality-adjusted life years: population-specific measurement of the quality component. Hong Kong Med. J. 17(Suppl 6), 17–21 (2011)PubMed S.M. McGhee, J. Brazier, C.L.K. Lam, L.C. Wong, J. Chau, A. Cheung, A. Ho, Quality-adjusted life years: population-specific measurement of the quality component. Hong Kong Med. J. 17(Suppl 6), 17–21 (2011)PubMed
35.
Zurück zum Zitat J.G. Howie, D.J. Heaney, M. Maxwell, J.J. Walker, A comparison of a patient enablement instrument (PEI) against two established satisfaction scales as an outcome measure of primary care consultations. Fam. Pract. 15(2), 165–171 (1998). doi:10.1093/fampra/15.2.165 CrossRefPubMed J.G. Howie, D.J. Heaney, M. Maxwell, J.J. Walker, A comparison of a patient enablement instrument (PEI) against two established satisfaction scales as an outcome measure of primary care consultations. Fam. Pract. 15(2), 165–171 (1998). doi:10.​1093/​fampra/​15.​2.​165 CrossRefPubMed
36.
Zurück zum Zitat C.L. Lam, N.Y. Yuen, S.W. Mercer, W. Wong, A pilot study on the validity and reliability of the patient enablement instrument (PEI) in a Chinese population. Fam. Pract. 27(4), 395–403 (2010). doi:10.1093/fampra/cmq021 CrossRefPubMed C.L. Lam, N.Y. Yuen, S.W. Mercer, W. Wong, A pilot study on the validity and reliability of the patient enablement instrument (PEI) in a Chinese population. Fam. Pract. 27(4), 395–403 (2010). doi:10.​1093/​fampra/​cmq021 CrossRefPubMed
37.
Zurück zum Zitat R. Jaeschke, J. Singer, G.H. Guyatt, Measurement of health status: ascertaining the minimal clinically important difference. Control Clin. Trials 10(4), 407–415 (1989)CrossRefPubMed R. Jaeschke, J. Singer, G.H. Guyatt, Measurement of health status: ascertaining the minimal clinically important difference. Control Clin. Trials 10(4), 407–415 (1989)CrossRefPubMed
39.
Zurück zum Zitat C.F. Snyder, N.K. Aaronson, A.K. Choucair, T.E. Elliott, J. Greenhalgh, M.Y. Halyard, R. Hess, D.M. Miller, B.B. Reeve, M. Santana, Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual. Life Res. 21(8), 1305–1314 (2012). doi:10.1007/s11136-011-0054-x CrossRefPubMed C.F. Snyder, N.K. Aaronson, A.K. Choucair, T.E. Elliott, J. Greenhalgh, M.Y. Halyard, R. Hess, D.M. Miller, B.B. Reeve, M. Santana, Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual. Life Res. 21(8), 1305–1314 (2012). doi:10.​1007/​s11136-011-0054-x CrossRefPubMed
40.
Zurück zum Zitat S. Ahmed, R.A. Berzon, D.A. Revicki, W.R. Lenderking, C.M. Moinpour, E. Basch, B.B. Reeve, A.W. Wu, on behalf of the International Society for Quality of Life Research: The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy. Med. Care 50(12), 1060–1070 (2012). doi:10.1097/MLR.0b013e318268aaff S. Ahmed, R.A. Berzon, D.A. Revicki, W.R. Lenderking, C.M. Moinpour, E. Basch, B.B. Reeve, A.W. Wu, on behalf of the International Society for Quality of Life Research: The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy. Med. Care 50(12), 1060–1070 (2012). doi:10.​1097/​MLR.​0b013e318268aaff​
Metadaten
Titel
Evaluation of patient-reported outcomes data in structured diabetes education intervention: 2-year follow-up data of patient empowerment programme
verfasst von
Carlos K. H. Wong
Cindy L. K. Lam
Eric Y. F. Wan
Anca K. C. Chan
C. H. Pak
Frank W. K. Chan
William C. W. Wong
Publikationsdatum
13.09.2016
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2016
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1015-5

Weitere Artikel der Ausgabe 2/2016

Endocrine 2/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.